Evidence mapPaperPMID 32052833Full record

ArticleEuropean heart journal2020

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel.

Jan Borén, M John Chapman, Ronald M Krauss, Chris J Packard, Jacob F Bentzon, Christoph J Binder, Mat J Daemen, Linda L Demer, Robert A Hegele, Stephen J Nicholls and 20 more

3 registry-linked trialsAbstract readConsensus Statement
In one paragraph

Article in European heart journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 733 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
733citing papers in PubMed, 10 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06606821 phase4recruitingstarted 2024, after this paper: background citation

The Effects of Tirzepatide on Coronary Plaque Lipid Content and Myocardial Microvascular Function in Overweight and Obese People With Coronary Disease - The IDEAL-COR Study

Ran2024Enrolled124Registered outcomes23Posted comparisons0ConditionsAtherosclerosis Cardiovascular Disease, Chronic Coronary Artery Disease, Coronary Artery Disease, Coronary Microvascular DysfunctionArmsPlacebo, Tirzepatide
Open the trial in the graph
NCT06841536 nacompletedstarted 2025, after this paper: background citation

Combined Effects of Statins and Exercise on Physiological Health Markers and Quality of Life in Patients With Dyslipidaemia

Ran2025Enrolled120Registered outcomes61Posted comparisons0ConditionsDyslipidemiasArmsAtorvastatin 80mg, Exercise
Open the trial in the graph
NCT07050134 naenrolling by invitationnot on this mapstarted 2025, after this paper: background citation

A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of DR10624 in Patients With Hypertriglyceridemia and Carotid Atherosclerotic Plaque

TypeinterventionalSponsorJunbo GeRan2025 to 2027Enrolled40ConditionsHypertriglyceridemia, Carotid Atherosclerotic PlaquesArmsDR10624 Injection;, DR10624 Injection Placebo (referred to as placebo)
3 · Its place in the literature

Who cites it

733 citing papers in PubMed, 10 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Effects of aged black garlic (ABG10+Frontiers in nutrition · 2026
    Trial
  16. Trial
  17. Trial
  18. Trial
  19. Review
  20. Article

673 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Jan BorénDepartment of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden.
M John ChapmanEndocrinology-Metabolism Division, Pitié-Salpêtrière University Hospital, Sorbonne University, Paris, France.
Ronald M KraussDepartment of Atherosclerosis Research, Children's Hospital Oakland Research Institute and UCSF, Oakland, CA 94609, USA.
Chris J PackardInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
Jacob F BentzonDepartment of Clinical Medicine, Heart Diseases, Aarhus University, Aarhus, Denmark.
Christoph J BinderDepartment of Laboratory Medicine, Medical University of Vienna, Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Mat J DaemenDepartment of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.
Linda L DemerDepartment of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Robert A HegeleDepartment of Medicine, Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
Stephen J NichollsMonash Cardiovascular Research Centre, Monash University, Melbourne, Australia.
Børge G NordestgaardDepartment of Clinical Biochemistry, The Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, University of Copenhagen, Denmark.
Gerald F WattsSchool of Medicine, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Australia.
Eric BruckertINSERM UMRS1166, Department of Endocrinology-Metabolism, ICAN - Institute of CardioMetabolism and Nutrition, AP-HP, Hopital de la Pitie, Paris, France.
Sergio FazioDepartments of Medicine, Physiology and Pharmacology, Knight Cardiovascular Institute, Center of Preventive Cardiology, Oregon Health & Science University, Portland, OR, USA.
Brian A FerenceCentre for Naturally Randomized Trials, University of Cambridge, Cambridge, UK.
Ian GrahamTrinity College Dublin, Dublin, Ireland.
Jay D HortonDepartment of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Ulf LandmesserDepartment of Cardiology, Charité - University Medicine Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, Berlin, Germany.
Ulrich LaufsKlinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Liebigstraße 20, Leipzig, Germany.
Luis MasanaResearch Unit of Lipids and Atherosclerosis, IISPV, CIBERDEM, University Rovira i Virgili, C. Sant Llorenç 21, Reus 43201, Spain.
Gerard PasterkampLaboratory of Clinical Chemistry, University Medical Center Utrecht, Utrecht, The Netherlands.
Frederick J RaalCarbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa.
Kausik K RayDepartment of Primary Care and Public Health, Imperial Centre for Cardiovascular Disease Prevention, Imperial College London, London, UK.
Heribert SchunkertDeutsches Herzzentrum München, Klinik für Herz- und Kreislauferkrankungen, Faculty of Medicine, Technische Universität München, Lazarettstr, Munich, Germany.
Marja-Riitta TaskinenResearch Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Bart van de SluisDepartment of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Olov WiklundDepartment of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden.
Lale TokgozogluDepartment of Cardiology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Alberico L CatapanoDepartment of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, and IRCCS MultiMedica, Milan, Italy.
Henry N GinsbergDepartment of Medicine, Irving Institute for Clinical and Translational Research, Columbia University, New York, NY, USA.

Funding

TRANSCRIPTIONAL REGULATION OF LDL RECEPTOR PROMOTERP01HL020948 · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · 1985 to 2005
$28.1M
NHLBI NIH HHS P01 HL020948
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AtherosclerosisCardiovascular DiseasesCholesterol, LDLConsensusHumansCholesterol, LDL

Identifiers

PMID32052833
PMCPMC7308544

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.